Cord Blood Study Provides Insights on Benefits, Limitations for Autism Treatment

by Admin | May 22, 2020 | News & Opinions

Children with autism without intellectual disability may benefit, but more research is needed DURHAM, N.C. — In a recent study, Duke researchers tested whether a single infusion of a unit of a child’s own or donor cord blood could improve social communication...

Clinical trial shows ability of stem cell-based topical solution to regrow hair

by Admin | May 18, 2020 | News & Opinions

Photo caption, “A more enriched adipose-derived stem cells-constituent extract (ADSC-CE) with stem cell proteins is obtained by disruption of the ADSC membrane using a low frequency of ultrasound wave.” Durham, NC – The results of a clinical trial released...

RMMS: The Regenerative Medicine Manufacturing Society Will Target Unmet Needs in 3D Bioprinting

by Admin | May 13, 2020 | News & Opinions

by Vanesa Listek 3D Printing | Bioprinting To deal with the challenges in regenerative medicine, in 2018, pioneer bioprinting expert Anthony Atala announced the foundation of an organization dedicated solely to advancing the field through manufacturing. Known as the...

Study shows stem cells constitute alternative approach for treating corneal scarring

by Admin | May 7, 2020 | News & Opinions

Durham, NC – Infection, inflammation, trauma, disease, contact lenses – all of these and more can lead to corneal scarring, which according to the World Health Organization is a leading cause of blindness worldwide. While corneal transplant remains the gold standard...

California stem cell advocates submit signatures for $5.5 billion bond measure

by Admin | May 5, 2020 | News & Opinions

By Dustin Gardiner- May 5, 2020, San Francisco Chronicle Supporters of a proposed $5.5 billion bond measure that would keep California’s stem cell research institute in business say they have submitted enough signatures to qualify it for the November ballot. The...

Mesoblast’s Stem Cell Therapy Shows 83% Survival in Ventilator-Dependent COVID-19 Patients

by Admin | Apr 25, 2020 | News & Opinions

April 24, 2020 – By Mark Terry – Melbourne, Australia and New York-based Mesoblast Limited announced that in a study of COVID-19 patients with moderate to severe acute respiratory distress syndrome (ARDS), there was 83% survival with two intravenous...